Assessment of Microbiome Signature for Predicting Prognosis of Gastrointestinal Cancers

The gut microbiome is increasingly recognized as playing a critical role in the prognosis and progression of gastrointestinal cancers, although its underlying mechanisms remain largely unelucidated. This review provides a thorough summary of current research investigating gut microbiome signatures as prognostic biomarkers in gastrointestinal cancers. We present an overview of recent studies examining microbial signatures as potential biomarkers for various gastrointestinal cancers, and discuss the potential benefits and challenges of employing these signatures in prognostic applications. Furthermore, we explore how these microbial signatures can be harnessed to enhance the detection, prevention, and treatment of gastrointestinal cancers, highlighting their clinical implications and future directions in cancer management.

Authors

Institutions

Publication Details

Journal
Current Cancer Therapy Reviews
Published
2024-10-14
DOI
https://doi.org/10.2174/0115733947333326240925092332
Citations
1
Primary Topic
Gastric Cancer Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.42
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Assessment of Microbiome Signature for Predicting Prognosis of Gastrointestinal Cancers

Shima Mehrabadi
1 citations
Current Cancer Therapy Reviews
Gastric Cancer Management and Outcomes
0.42
article

Assessment of Microbiome Signature for Predicting Prognosis of Gastrointestinal Cancers

Shima Mehrabadi
article en
1 citations

Abstract

The gut microbiome is increasingly recognized as playing a critical role in the prognosis and progression of gastrointestinal cancers, although its underlying mechanisms remain largely unelucidated. This review provides a thorough summary of current research investigating gut microbiome signatures as prognostic biomarkers in gastrointestinal cancers. We present an overview of recent studies examining microbial signatures as potential biomarkers for various gastrointestinal cancers, and discuss the potential benefits and challenges of employing these signatures in prognostic applications. Furthermore, we explore how these microbial signatures can be harnessed to enhance the detection, prevention, and treatment of gastrointestinal cancers, highlighting their clinical implications and future directions in cancer management.

Current Cancer Therapy ReviewsVol. 22(1)
Mashhad University of Medical Sciences (IR)
Good health and well-being
Openalex Percentile: Top 32%
Gastric Cancer Management and Outcomes
0.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.